系统性红斑狼疮相关血栓性微血管炎的临床表型与病因亚型
该回顾性队列研究纳入124例SLE-TMA成人患者,发现48%为无血液学表现的肾脏局限型TMA,其慢性血管病变和肾复发风险更高,而血液学型死亡率更高。病因分型以疑似补体介导TMA(59.7%)和抗磷脂综合征肾病(34.7%)为主,支持基于表型的诊断框架并强调肾活检的重要性。
要点
- 近半数SLE-TMA为肾脏局限型,需肾活检确诊。
- 肾脏局限型慢性血管病变和肾复发风险更高。
- 血液学型TMA死亡率更高,TTP样者肾脏恢复较好。
核心结论
- SLE相关TMA常表现为肾脏局限型综合征,需活检诊断。
- 基于表型的方法可识别具有不同肾脏轨迹的临床相关亚组。
研究设计与样本
- 回顾性队列研究,纳入2004至2024年三级转诊中心124例成人SLE-TMA患者。
- TMA由血液学标准和/或肾活检发现定义,分为肾脏-血液学型(RH-TMA)和肾脏局限型(RL-TMA)。
主要发现
- 48%的病例表现为无血液学表现的RL-TMA。
- RL-TMA与慢性血管病变患病率更高相关(aOR 2.84,95%CI 1.04-7.78),肾复发风险更高(aHR 2.67,95%CI 1.17-6.09)。
- RH-TMA死亡率更高;组织学活动模式(急性vs慢性病变)与肾脏结局无关。
- 病因判定提示三种主要表型:疑似补体介导TMA(59.7%)、抗磷脂综合征肾病(34.7%)、TTP样TMA(5.6%)。
- TTP样表现患者血液学受累更严重,但幸存者肾脏恢复良好。
临床怎么用
- 对无 overt 血液学特征的SLE患者,应考虑肾活检以诊断肾脏局限型TMA。
- 基于临床表型(RH-TMA vs RL-TMA)进行分层管理,关注RL-TMA的肾复发风险。
局限性
- 单中心回顾性研究,样本量有限。
- 病因判定未系统使用生物标志物确认。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Thrombotic microangiopathy (TMA) is a rare and severe complication of systemic lupus erythematosus (SLE). While classically defined by microangiopathic hemolytic anemia, thrombocytopenia, and organ damage, TMA may also present as a renal-limited process requiring histologic diagnosis. Data characterizing the clinical phenotypes, histologic patterns, etiologic subtypes, and outcomes of SLE-associated TMA remain limited. METHODS: We conducted a retrospective cohort study of adults with SLE-TMA diagnosed between 2004 and 2024 at a tertiary referral center. TMA was defined by either hematologic criteria and/or kidney biopsy findings. Patients were categorized as having renal-hematologic TMA (RH-TMA) or renal-limited TMA (RL-TMA). Etiologic adjudication was performed using predefined clinical criteria, incorporating validated probability scores and serologic evaluation. Clinical characteristics, histologic findings, treatment, and long-term outcomes were analyzed by survival analyses. RESULTS: A total of 124 patients were included. The median age was 29 years and 90% were female. Kidney biopsy was performed in 81% of cases. Nearly half of cases (48%) presented as RL-TMA without hematologic manifestations. Compared with RH-TMA, RL-TMA was associated with a higher prevalence of chronic vascular lesions (aOR 2.84, 95%CI 1.04-7.78) and an increased risk of renal relapse (aHR 2.67, 95%CI 1.17-6.09), while mortality was higher in RH-TMA. Histologic activity pattern (acute vs. chronic lesions) was not associated with renal outcomes. Etiologic adjudication suggested three predominant phenotypes: suspected complement-mediated TMA (59.7%), antiphospholipid syndrome nephropathy (34.7%), and TTP-like TMA (5.6%). Patients with TTP-like presentations had more severe hematologic involvement but favorable renal recovery among survivors. CONCLUSION: SLE-associated TMA frequently presents as a renal-limited syndrome requiring biopsy for diagnosis. A phenotype-based approach identifies clinically relevant subgroups with distinct renal trajectories, even in the absence of systematic biomarker confirmation. These findings support a pragmatic diagnostic framework for SLE-TMA and highlight the importance of kidney biopsy in patients without overt hematologic features.
引用
- Fortanell-Meza A, Sánchez-Mejía DE, Barrera-Vargas A, et al. Clinical phenotypes and etiologic subtypes of thrombotic microangiopathy in systemic lupus erythematosus. Nephrol Dial Transplant. 2026. PMID: 42545749. doi:10.1093/ndt/gfag167
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。